Unverified50% confidenceFactExact time
Insilico Medicine's rentosertib had the TNIK target identified by the PandaOmics target discovery platform and the small molecule designed by the Chemistry42 generative chemistry system, and the company describes it as the first candidate drug in which AI led both target discovery and molecular design.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
10/17/2026
First Seen
Valid until: 1/15/2027
Sources
Related Entities
Related Claims
UnverifiedThe protein binders designed by Claude were actually constructed and tested by two external biotechnology companies, Adaptive Biotechnologies and Twist Bioscience.59% similarUnverifiedTechCrunch has not yet disclosed Intero Biosystems' specific technical approach, founding team background, funding stage, or business model details.56% similarUnverifiedAnthropic quietly launched a molecular biology laboratory earlier this year.52% similarUnverifiedThe team announced the open-sourcing of the SynthID Bio tool for the research community to continue building upon.51% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1055122API
curl https://kongchang.com/api/v1/knowledge/claims/1055122MCP
get_claim(id=1055122)